Enzo Biochem, Inc.
ENZ
$0.464
-$0.015-3.13%
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -17.45% | -6.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.45% | -6.18% | |||
| Cost of Revenue | -8.66% | 0.40% | |||
| Gross Profit | -29.19% | -13.74% | |||
| SG&A Expenses | 1.17% | 2.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.49% | 1.25% | |||
| Operating Income | -35.91% | -30.45% | |||
| Income Before Tax | -167.51% | 46.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -167.51% | 46.13% | |||
| Earnings from Discontinued Operations | 97.51% | -1,276.04% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 74.77% | -343.08% | |||
| EBIT | -35.91% | -30.45% | |||
| EBITDA | -45.70% | -32.88% | |||
| EPS Basic | 75.30% | -343.22% | |||
| Normalized Basic EPS | -171.85% | 48.08% | |||
| EPS Diluted | 73.23% | -343.22% | |||
| Normalized Diluted EPS | -171.85% | 48.08% | |||
| Average Basic Shares Outstanding | 2.64% | -0.61% | |||
| Average Diluted Shares Outstanding | 2.64% | -0.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
